| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $25K | -86.3% | -87.2% |
| R&D Expense | $4.0M | -20.8% | -31.4% |
| SG&A Expense | $2.2M | -36.1% | -43.1% |
| Operating Income | -$6.2M | +29.3% | +49.9% |
| Pre-tax Income | -$6.0M | +19.6% | +49.6% |
| Income Tax | $3K | +50.0% | -57.1% |
| Net Income | -$6.0M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $22.1M | -26.0% | -7.3% |
| Current Assets | $23.0M | -25.9% | -57.7% |
| Total Assets | $43.7M | -16.9% | -44.5% |
| Current Liabilities | $9.5M | -15.1% | -36.6% |
| Total Liabilities | $48.0M | -5.7% | -17.4% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$22.8M | — | — |
| Capital Expenditures | $20K | — | — |
| Investing Cash Flow | -$2K | — | — |
| Financing Cash Flow | $4.3M | — | — |
| Free Cash Flow | -$22.8M | — | — |
| +19.5% |
| +49.6% |
| EPS (Basic) | -$3.38 | +38.7% | -1777.8% |
| EPS (Diluted) | -$3.38 | +38.7% | -1777.8% |
| -$4.3M |
| -366.8% |
| -121.0% |